Merck Honored with CPhI Excellence in Pharma AwardsIssue: November 29, 2016
| Categories: Formulation, Regulatory topics, Merck topics
![]() CPhI Pharma Awards recently honored Merck for groundbreaking innovations in technology, formulation, regulatory procedures and product development. Parteck® SRP 80, a functional direct compressible excipient designed for oral sustained release formulations, won the technology award for "Excipients and Formulation Development.” The excipient is fully synthetic for batch-to-batch and performance consistency and enhances the bioavailability of actives. Our Emprove® program won for “Regulatory Procedures and Compliance.” The program provides documentation and regulatory information on materials used in the manufacture of drug products. This information enhances transparency, facilitates manufacturers’ risk assessment workflows and supplier qualification. In addition, the CEO of our life science business, Udit Batra was named "CEO of the Year" for his commitment to furthering life science innovation globally. Recognition from this prestigious organization showcases some of our world-class technologies and solutions pharmaceutical customers working to treat disease. Click here for more information. In This Same Issue |
Recent Articles
Article Search
Article Archives
Events
Webinars
|